Merz Aesthetics has announced a partnership with Oscar- and Emmy-award-winning actor, author and entrepreneur, Gwyneth Paltrow, for the launch of the company’s first global campaign for Xeomin (incobotulinumtoxinA). Xeomin (pronounced phonetically: Zeo-min) is an FDA-approved anti-wrinkle injection for frown lines that is purified to remove unnecessary proteins. Women have been using Xeomin for nearly 10 years to give wrinkles between the eyebrows a smoother appearance. As the global face of the brand, Paltrow joins Xeomin in standing with women who choose beauty on their own terms and do so with proven products.
Read more at Business Wire >>